Clinical Trials Logo

Citation(s)

Phase 1 Study of the Safety, Reactogenicity and Immunogenicity of AMA1-C1/ISA 720: A Blood Stage Vaccine for Plasmodium Falciparum

Details for clinical trial NCT00487916